 |
 Previous Article | Next Article 
The Journal of Neuroscience, June 15, 2002, 22(12):4833-4841
A Novel Function of Monomeric Amyloid  -Protein Serving as an
Antioxidant Molecule against Metal-Induced Oxidative Damage
Kun
Zou,
Jian-Sheng
Gong,
Katsuhiko
Yanagisawa, and
Makoto
Michikawa
Department of Dementia Research, National Institute for Longevity
Sciences, Obu, Aichi 474-8522, Japan
Aggregated and oligomeric amyloid  -protein (A) is known
to exhibit neurotoxicity. However, the action of A monomers on neurons is not fully understood. We have studied aggregation
state-dependent actions of A and found an oligomer-specific effect
of A on lipid metabolism in neurons (Michikawa et al., 2001). Here,
we show a novel function of monomeric A1-40, which is the major
species found in physiological fluid, as a natural antioxidant molecule that prevents neuronal death caused by transition metal-induced oxidative damage. Monomeric A1-40, which is demonstrated by
SDS-PAGE after treatment with glutaraldehyde, protects neurons cultured in a medium containing 1.5 µM Fe(II) without
antioxidant molecules. Metal ion chelators such as EDTA, CDTA
(trans-1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid), and DTPA
(diethylenetriamine-N,N,N',N",N"-penta-acetic acid, an iron-binding protein, transferrin, and antioxidant
scavengers such as catalase, glutathione, and vitamin E also inhibit
neuronal death under the same conditions. Monomeric A1-40 inhibits
neuronal death caused by Cu(II), Fe(II), and Fe(III) but does not
protect neurons against H2O2-induced damage.
Monomeric A1-40 inhibits the reduction of Fe(III) induced by
vitamin C and the generation of superoxides and prevents lipid
peroxidation induced by Fe(II). A1-42 remaining as a monomer also
exhibits antioxidant and neuroprotective effects. In contrast,
oligomeric and aggregated A1-40 and A1-42 lose their
neuroprotective activity. These results indicate that monomeric A
protects neurons by quenching metal-inducible oxygen radical generation
and thereby inhibiting neurotoxicity. Because aggregated A is known
to be an oxygen radical generator, our results provide a novel concept
that the aggregation-dependent biological effects of A are
dualistic, being either an oxygen radical generator or its inhibitor.
Key words:
Alzheimer's disease; amyloid -protein; transition
metals; oxygen radicals; antioxidant; neuronal death
Copyright © 2002 Society for Neuroscience 0270-6474/02/22124833-09$05.00/0
This article has been cited by other articles:
|
|
|
|
 
K. Zou, T. Maeda, A. Watanabe, J. Liu, S. Liu, R. Oba, Y.-i. Satoh, H. Komano, and M. Michikawa
A{beta}42-to-A{beta}40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
J. Biol. Chem.,
November 13, 2009;
284(46):
31914 - 31920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ariga, M. P. McDonald, and R. K. Yu
Thematic Review Series: Sphingolipids. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review
J. Lipid Res.,
June 1, 2008;
49(6):
1157 - 1175.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Zou, H. Yamaguchi, H. Akatsu, T. Sakamoto, M. Ko, K. Mizoguchi, J.-S. Gong, W. Yu, T. Yamamoto, K. Kosaka, et al.
Angiotensin-Converting Enzyme Converts Amyloid {beta}-Protein 1 42 (A{beta}1 42) to A{beta}1 40, and Its Inhibition Enhances Brain A{beta} Deposition
J. Neurosci.,
August 8, 2007;
27(32):
8628 - 8635.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-g. Lee, X. Zhu, R. J. Castellani, A. Nunomura, G. Perry, and M. A. Smith
Amyloid-beta in Alzheimer Disease: The Null versus the Alternate Hypotheses
J. Pharmacol. Exp. Ther.,
June 1, 2007;
321(3):
823 - 829.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Malm, H. Iivonen, G. Goldsteins, V. Keksa-Goldsteine, T. Ahtoniemi, K. Kanninen, A. Salminen, S. Auriola, T. Van Groen, H. Tanila, et al.
Pyrrolidine Dithiocarbamate Activates Akt and Improves Spatial Learning in APP/PS1 Mice without Affecting {beta}-Amyloid Burden
J. Neurosci.,
April 4, 2007;
27(14):
3712 - 3721.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Pierrot, S. F. Santos, C. Feyt, M. Morel, J.-P. Brion, and J.-N. Octave
Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-beta Accumulation
J. Biol. Chem.,
December 29, 2006;
281(52):
39907 - 39914.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Nunomura, R. J. Castellani, H.-g. Lee, P. I. Moreira, X. Zhu, G. Perry, and M. A. Smith
Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream.
Sci. Aging Knowl. Environ.,
March 22, 2006;
2006(8):
pe10 - pe10.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G. F. Z. da Silva, W. M. Tay, and L.-J. Ming
Catechol Oxidase-like Oxidation Chemistry of the 1-20 and 1-16 Fragments of Alzheimer's Disease-related {beta}-Amyloid Peptide: THEIR STRUCTURE-ACTIVITY CORRELATION AND THE FATE OF HYDROGEN PEROXIDE
J. Biol. Chem.,
April 29, 2005;
280(17):
16601 - 16609.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. J. Nelson and D. L. Alkon
Oxidation of Cholesterol by Amyloid Precursor Protein and {beta}-Amyloid Peptide
J. Biol. Chem.,
February 25, 2005;
280(8):
7377 - 7387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-g. Lee, P. I. Moreira, X. Zhu, M. A. Smith, and G. Perry
Staying Connected: Synapses in Alzheimer Disease
Am. J. Pathol.,
November 1, 2004;
165(5):
1461 - 1464.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Li, L. Yang, K. Lindholm, Y. Konishi, X. Yue, H. Hampel, D. Zhang, and Y. Shen
Tumor Necrosis Factor Death Receptor Signaling Cascade Is Required for Amyloid-{beta} Protein-Induced Neuron Death
J. Neurosci.,
February 18, 2004;
24(7):
1760 - 1771.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. I. Bush, C. L. Masters, and R. E. Tanzi
Copper, {beta}-amyloid, and Alzheimer's disease: Tapping a sensitive connection
PNAS,
September 30, 2003;
100(20):
11193 - 11194.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Rai, J. J. Tate, and T. G. Cooper
Ure2, a Prion Precursor with Homology to Glutathione S-Transferase, Protects Saccharomyces cerevisiae Cells from Heavy Metal Ion and Oxidant Toxicity
J. Biol. Chem.,
April 4, 2003;
278(15):
12826 - 12833.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. A. Lashuel, D. M. Hartley, D. Balakhaneh, A. Aggarwal, S. Teichberg, and D. J. E. Callaway
New Class of Inhibitors of Amyloid-beta Fibril Formation. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASE
J. Biol. Chem.,
November 1, 2002;
277(45):
42881 - 42890.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
